These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 10575901)

  • 1. [Determinant factors for the use of screening for cervical cancer in Friuli Venezia Giulia].
    Abrami R; Cattaneo A
    Minerva Ginecol; 1999 Sep; 51(9):335-41. PubMed ID: 10575901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of cervical cancer screening program at a rural community of South Africa.
    Hoque M; Hoque E; Kader SB
    East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case-control study of the protective benefit of cervical screening against invasive cervical cancer in NSW women.
    Yang B; Morrell S; Zuo Y; Roder D; Tracey E; Jelfs P
    Cancer Causes Control; 2008 Aug; 19(6):569-76. PubMed ID: 18286380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical cancer screening in a rural population of Zimbabwe.
    Thistle PJ; Chirenje ZM
    Cent Afr J Med; 1997 Sep; 43(9):246-51. PubMed ID: 9509642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physician recommendation for papanicolaou testing among U.S. women, 2000.
    Coughlin SS; Breslau ES; Thompson T; Benard VB
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1143-8. PubMed ID: 15894664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
    Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
    J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Organized cervical cancer screening for underpriviledged women].
    Piana L; Leandri FX; Jacqueme B; Heid P; Corti J; Andrac-Meyer L; Sancho-Garnier H
    Bull Cancer; 2007 May; 94(5):461-7. PubMed ID: 17535784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between sexual behavior and cervical cancer screening.
    Smith AM; Heywood W; Ryall R; Shelley JM; Pitts MK; Richters J; Simpson JM; Patrick K
    J Womens Health (Larchmt); 2011 Jul; 20(7):1091-6. PubMed ID: 21682554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Assessment of the use of Pap test in a sample of pregnant women].
    Dindelli M; Parazzini F; Rabaiotti E; Liati P; Ferrari A
    Minerva Ginecol; 1990; 42(7-8):305-8. PubMed ID: 2293073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of nursing interventions to increase pap smear test screening.
    Guvenc G; Akyuz A; Yenen MC
    Res Nurs Health; 2013 Apr; 36(2):146-57. PubMed ID: 23335354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knowledge and attitudes as predictors of cervical cancer screening among women in a Venezuelan urban area.
    Núñez-Troconis J; Tulliani E; Gabriela Martínez M; Fernández N
    Invest Clin; 2013 Mar; 54(1):20-33. PubMed ID: 23781710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the Pap test by a population group in Buenos Aires.
    Klimovsky E; Matos E
    Bull Pan Am Health Organ; 1996 Dec; 30(4):313-21. PubMed ID: 9041742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical cancer screening among Taiwanese women: a transtheoretical approach.
    Tung WC; Lu M; Cook D
    Oncol Nurs Forum; 2010 Jul; 37(4):E288-94. PubMed ID: 20591792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cytological screening turned out effective also for adenocarcinoma: a population-based case-control study in Trento, Italy.
    Crocetti E; Battisti L; Betta A; Palma PD; Paci E; Piffer S; Pojer A; Polla E; Zappa M
    Eur J Cancer Prev; 2007 Dec; 16(6):564-7. PubMed ID: 18090131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Report from the CDC. Pap test intervals used by physicians serving low-income women through the National Breast and Cervical Cancer Early Detection Program.
    Cooper CP; Saraiya M; McLean TA; Hannan J; Liesmann JM; Rose SW; Lawson HW
    J Womens Health (Larchmt); 2005 Oct; 14(8):670-8. PubMed ID: 16232098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Papanicolaou smear screening of women with intellectual disabilities: a cross-sectional survey in Taiwan.
    Lin LP; Lin JD; Sung CL; Liu TW; Liu YL; Chen LM; Chu CM
    Res Dev Disabil; 2010; 31(2):403-9. PubMed ID: 19897337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical cancer screening among U.S. women: analyses of the 2000 National Health Interview Survey.
    Hewitt M; Devesa SS; Breen N
    Prev Med; 2004 Aug; 39(2):270-8. PubMed ID: 15226035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with Pap smear screening among French women visiting a general practitioner in the Rhône-Alpes region.
    Oussaid N; Lutringer-Magnin D; Barone G; Haesebaert J; Lasset C
    Rev Epidemiol Sante Publique; 2013 Oct; 61(5):437-45. PubMed ID: 24012357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of cervical cancer screening programme in the Harare City Health Department, Zimbabwe.
    Moyo IM; Koni NP; Makunike B; Hipshman J; Makaure HK; Gumbo N
    Cent Afr J Med; 1997 Aug; 43(8):223-5. PubMed ID: 9431759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perceptions and concerns of women undergoing Pap smear examination in a tertiary care hospital of India.
    Tiwari A; Kishore J; Tiwari A
    Indian J Cancer; 2011; 48(4):477-82. PubMed ID: 22293264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.